Clinical Pathology: General Principles, Microbiology

• Accurate data regarding laboratory-acquired mycoses are not available due to a general lack of required reporting to public health agencies. Reporting acquired infections in laboratories is currently required coccidioidomycosis in California and Arizona, blastomycosis in Louisiana and Wisconsin, and histoplasmosis in Kentucky and Wisconsin.

• Because filamentous fungi produce conidia or spores that can easily become airborne, special safety precautions specific to mycology are required. Examination of molds should be performed in a biologic safety cabinet (BSC), not only to prevent contamination of the laboratory environment, but also to avert acquisition of dimorphic fungi, such as Coccidioides immitis, Blastomyces dermatitidis, and Histoplasma capsulatum. Because yeast do not produce airborne spores, they can be processed on the open work bench.

• Standard safety precautions in mycology require that slide cultures never be prepared if dimorphic fungi are suspected. Slide culture procedures are reserved for the workup of low-virulence fungi. Wet mount preparations are recommended for presumptive identification of dimorphic fungi, and screw-cap tubes of slanted media or plated media can be used to grow nondimorphic molds. However, when the latter are used, oxygen-permeable tape or shrink seals must be used to contain the spores within the plate.

• Although it is recommended that a designated laboratory under negative pressure be used to safely culture and identify molds, it is not a requirement. Handling and processing fungal isolates, including molds, can be safely performed using a certified BSC in the open microbiology laboratory.

• Yeast are routinely identified by commercially prepared biochemical-based assays. Identification of molds includes DNA probe assays for dimorphic fungi, microscopic morphology, and differential or selective media. Molecular methods for identification are rapidly replacing phenotypic assays, such as gene sequencing, nucleic acid amplification, and mass spectrophotometry.

Chosewood LC, Wilson DE, eds: Centers for Disease Control and Prevention and National Institutes of Health. Biosafety in microbiological and biomedical laboratories. 5th ed. Washington, DC: US Department of Health and Human Services; 2006.

Fleming DO, Hunt SL, eds: Mycotic agents of human disease. In Biological safety principles and practices, 4th ed. W.A. Schell: pp 163-178.

 
* = Required 
* Note Title
* Note